359
Participants
Start Date
January 4, 2022
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2026
Zidesamtinib (NVL-520)
Oral tablet of zidesamtinib (NVL-520)
RECRUITING
Netherlands Cancer Institute, Amsterdam
RECRUITING
Chris O'Brien Lifehouse, Camperdown
RECRUITING
Peter MacCallum Cancer Centre, Melbourne
RECRUITING
University Hospital Leuven, Leuven
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
NYU Langone Health, New York
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
National Cancer Center, Gyeonggi-do
RECRUITING
University Hospital of A Coruña, A Coruña
RECRUITING
Fox Chase Cancer Center, Philadelphia
RECRUITING
Georgetown University Medical Center, Washington D.C.
RECRUITING
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
RECRUITING
Istituto Europeo di Oncologia, Milan
RECRUITING
NEXT Oncology - Virginia Cancer Specialists, Fairfax
RECRUITING
Gregorio Marañón Hospital, Madrid
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Hospital Universitario HM Sanchinarro, Madrid
RECRUITING
Atrium Health Levine Cancer Institute, Charlotte
RECRUITING
Claudius Regaud Institute, Toulouse
RECRUITING
University of Miami, Coral Gables
RECRUITING
Istituto Oncologico Veneto, Padua
RECRUITING
Sarah Cannon Research Institute, Nashville
RECRUITING
Chung Shan Medical University Hospital, Taichung
RECRUITING
Ohio State University, Columbus
RECRUITING
CHU de Nantes, Nantes
RECRUITING
Ospedale Santa Maria delle Croci, Ravenna
RECRUITING
Henry Ford Cancer Institute, Detroit
RECRUITING
Università Politecnica Marche, Ancona
RECRUITING
University of Chicago, Chicago
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
Centre Legon Berard, Lyon
RECRUITING
IRCCS Istituto Tumori Giovanni Paolo II, Bari
ACTIVE_NOT_RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
University of Colorado Cancer Center, Denver
RECRUITING
UCI Medical Center, Orange
RECRUITING
Stanford Medicine, Palo Alto
RECRUITING
Institute Gustave Roussy, Villejuif
RECRUITING
UC Davis Comprehensive Cancer Center, Sacramento
RECRUITING
University of Washington / Fred Hutchinson Cancer Center, Seattle
RECRUITING
National University Hospital Singapore, Singapore
RECRUITING
National Cancer Centre Singapore, Singapore
RECRUITING
National Cheng Kung University Hospital, Tainan City
RECRUITING
Mass General Hospital, Boston
RECRUITING
Dana-Farber Cancer Institute, Boston
RECRUITING
Cross Cancer Institute, Edmonton
RECRUITING
Princess Margaret Cancer Research, Toronto
RECRUITING
Cologne University Hospital, Cologne
RECRUITING
University Medical Centre Groningen, Groningen
RECRUITING
Samsung Medical Center, Seoul
RECRUITING
Istituto Nazionale Tumori Regina Elena, Rome
RECRUITING
Shizuoka Cancer Center, Nakatogari
RECRUITING
Okayama University Hospital, Okayama
RECRUITING
Kindai University, Osaka
RECRUITING
National Cancer Center Hospital, Tokyo
RECRUITING
Japanese Foundation for Cancer Research, Tokyo
RECRUITING
Wakayama Medical University Hospital, Wakayama
RECRUITING
Kanagawa Cancer Center, Yokohama
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Yonsei University Health System, Seoul
RECRUITING
UOMI Cancer Center - Clinica Tres Torres, Barcelona
RECRUITING
Vall d'Hebron University Hospital, Barcelona
RECRUITING
Royal Marsden Hospital, London
RECRUITING
Christie NHS Foundation Trust, Manchester
Lead Sponsor
Nuvalent Inc.
INDUSTRY